Alaunos Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.06 at 07:01 AM on Oct 13, then ran to $4.32 +308% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is TCRT up today? It is at $1.77 (+1.14%), and our scanner flagged it 249 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TCRT spikes, and full due diligence on TCRT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TCRT 249 times in the last 30 days. Create a free account to track $TCRT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TCRT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TCRT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystRegained listing compliance, from the latest SEC filing. Read it →Across every filing on file, supply equal to 32.3% of the tradeable float is in play - 32.3% has already been sold.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
767,123 new shares · About $1.1M in size · Priced at $1.459/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Jerman Michael Allen Director | Acquired (grant/award) | +21K 0.8% of company | added 88% | 45K | $16K at $0.740 | Oct 6, 26 |
Vieser Jaime Director | Acquired (grant/award) | +23K 0.9% of company | added 48% | 70K | $17K at $0.740 | Oct 6, 26 |
Postma Robert W Director | Acquired (grant/award) | +22K 0.9% of company | added 37% | 80K | $16K at $0.740 | Oct 6, 26 |
Weis Holger Officer | Acquired (grant/award) | +24K 0.9% of company | added 92% | 49K | $17K at $0.740 | Oct 6, 26 |
Weis Holger Officer | Acquired (grant/award) | +4K 0.2% of company | added 21% | 25K | $9K at $2.01 | Aug 6, 26 |
Postma Robert W Director | Acquired (grant/award) | +8K 0.3% of company | added 17% | 59K | $16K at $1.92 | Jul 23, 26 |
Vieser Jaime Director | Acquired (grant/award) | +9K 0.3% of company | added 23% | 48K | $17K at $1.92 | Jul 23, 26 |
Weis Holger Officer | Acquired (grant/award) | +5K 0.2% of company | added 28% | 21K | $9K at $1.92 | Jul 23, 26 |
Jerman Michael Allen Director | Acquired (grant/award) | +8K 0.3% of company | added 52% | 24K | $16K at $1.92 | Jul 23, 26 |
Weis Holger Officer | Acquired (grant/award) | +4K 0.2% of company | added 31% | 17K | $9K at $2.26 | Jun 30, 26 |
Weis Holger Officer | Acquired (grant/award) | +8K 0.3% of company | added 100% | 13K | $18K at $2.26 | Jun 12, 26 |
Weis Holger Officer | Acquired (grant/award) | +4K 0.1% of company | added 100% | 5K | $9K at $2.37 | May 22, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on TCRT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TCRT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TCRT last traded at $1.77, up 1.14% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Alaunos Therapeutics, Inc. Common Stock (TCRT) is next expected to report earnings on Friday, November 13, 2026, about 10 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TCRT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TCRT 249 times in the last 30 days.
TCRT (Alaunos Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $5M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TCRT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TCRT discussion
Sign in to ask a question or join the discussion.